In an era of increasingly personalized healthcare, Elizabeth Philp has become a leading figure of innovation, especially in the fast-evolving field of compounded pharmacy. As the chief executive and co-founder of Roseway Labs, Philp is at the helm of a drive to make bespoke medications more obtainable, disrupting the standard one-size-fits-all app